Lupin gets USFDA nod to sell Sertraline tablets

New Delhi, Feb 7 (UNI) Drug maker Lupin Ltd today said the United States Food and Drug Administration has approved the company's Abbreviated New Drug Application (ANDA) to market Sertraline Hydrochloride tablets.

The drug is indicated for the treatment of major depressive disorder.

The company's Sertraline Tablets are the AB-rated generic equivalent to Pfizer's Zoloft tablets.

The brand product had annual sales of nearly 2.1 billion dollars for the 12-month period ended December 2006, according to IMS Health.

With this approval, Lupin now has 18 ANDAs approved by the US FDA.

UNI